{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:45:24Z","timestamp":1782780324119,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2024YFF0728800"],"award-info":[{"award-number":["2024YFF0728800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences","award":["2023-PT180-01"],"award-info":[{"award-number":["2023-PT180-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lung cancer remains the malignant tumor with the highest global incidence and mortality, posing a severe threat to public health. Peroxiredoxin 3 (PRDX3), a well-characterized ferroptosis biomarker, has been implicated in lung cancer progression. Accumulating evidence suggests that PRDX3 may serve as a core gene and potential biomarker, which is critical for elucidating pathogenesis, improving diagnostic accuracy, and developing targeted therapeutic strategies for lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To systematically investigate the expression pattern of PRDX3 and its clinical relevance in lung cancer, we integrated multiple bioinformatics tools and public datasets to analyze PRDX3 expression across pan-cancer cohorts, major lung cancer subtypes, and patient subgroups stratified by sex, age, and clinical stage. Furthermore, we evaluated the correlation between PRDX3 expression and immunotherapeutic-related factors, and performed multivariate survival analysis to validate its independent prognostic value. Additionally, protein-protein interaction (PPI) networking and co-expression analysis were employed to explore the functional interactions of PRDX3 with core ferroptosis regulators and immune microenvironment modulators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PRDX3 was significantly upregulated in multiple malignant tumors, including LUAD and LUSC, with minimal variations in expression levels across different sex, age, and clinical stage subgroups. High PRDX3 expression was independently associated with significantly poorer clinical prognosis in lung cancer, particularly in the LUAD subtype. Pathway enrichment analysis revealed that immune activation, immune inhibition, and MHC molecule-related signaling pathways were closely correlated with altered PRDX3 expression in both LUAD and LUSC, with distinct subtype-specific patterns. PPI networking demonstrated that PRDX3 exhibited positive co-expression with core ferroptosis regulators (GPX4, TXN2) and interacted with components of the thioredoxin system (TXNRD2, TXN), indicating its potential involvement in regulating cellular redox homeostasis and ferroptosis. Single-cell analysis further confirmed PRDX3 expression in lung cancer cells and key immune cell subsets (T cells, macrophages), with higher expression levels observed in LUAD than in LUSC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These correlative findings suggest that PRDX3 may play a pivotal role in lung cancer pathogenesis, potentially through mechanisms involving ferroptosis regulation via interaction with GPX4 and the thioredoxin system, redox homeostasis maintenance, and subtype-specific immune microenvironment modulation. Collectively, PRDX3 represents a promising independent prognostic biomarker for lung cancer, especially for LUAD, and a potential therapeutic target for ferroptosis-based and immunotherapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-026-03703-5","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:27:08Z","timestamp":1778041628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The integrated analysis of PRDX3 in lung cancer: biomarker potential and therapeutic target prospects"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2867-7382","authenticated-orcid":false,"given":"Qi","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"3","key":"3703_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"3703_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3703_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3703_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Chen C, Zhao C, Li T, Ma L, Jiang J, Duan Z, Si Q, Chuang TH, Xiang R, Luo Y. Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer. Signal Transduct Target Ther. 2024;9(1):64.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3703_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","volume":"31","author":"Z Wang","year":"2024","unstructured":"Wang Z, Shen N, Wang Z, Yu L, Yang S, Wang Y, Liu Y, Han G, Zhang Q. TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11\/xCT K11-linked ubiquitination and degradation. Cell Death Differ. 2024;31(1):53\u201364.","journal-title":"Cell Death Differ"},{"issue":"19","key":"3703_CR6","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.3390\/ijms241914614","volume":"24","author":"X Wei","year":"2023","unstructured":"Wei X, Li X, Hu S, Cheng J, Cai R. Regulation of Ferroptosis in Lung Adenocarcinoma. Int J Mol Sci. 2023;24(19):14614.","journal-title":"Int J Mol Sci"},{"issue":"21","key":"3703_CR7","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1016\/j.molcel.2023.09.025","volume":"83","author":"S Cui","year":"2023","unstructured":"Cui S, Ghai A, Deng Y, Li S, Zhang R, Egbulefu C, Liang G, Achilefu S, Ye J. Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases. Mol Cell. 2023;83(21):3931\u2013e39395.","journal-title":"Mol Cell"},{"issue":"21","key":"3703_CR8","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"key":"3703_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, Creighton CJ, Varambally S. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"issue":"3","key":"3703_CR10","first-page":"100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov (Camb). 2024;5(3):100625.","journal-title":"Innov (Camb)"},{"issue":"12","key":"3703_CR11","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1038\/s41388-018-0588-2","volume":"38","author":"L Cai","year":"2019","unstructured":"Cai L, Lin S, Girard L, et al. LCE: an open web portal to explore gene expression and clinical associations in lung cancer. Oncogene. 2019;38(12):2551\u201364.","journal-title":"Oncogene"},{"issue":"20","key":"3703_CR12","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, Chu KC, Wong CY, Lau CY, Chen I, Chan NW, Zhang J. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200\u20132.","journal-title":"Bioinformatics"},{"issue":"D1","key":"3703_CR13","doi-asserted-by":"publisher","first-page":"D1658","DOI":"10.1093\/nar\/gkaf1235","volume":"54","author":"X Meng","year":"2026","unstructured":"Meng X, Nie Z, Wang Q, Hu Y, Deng Y, Ai N, Huang Z, Li Y, Yuan Y, Xiao J, Zeng J, Li G, Jiang L. TE-SCALE: a comprehensive database for exploring transposable element expression across human cancers at single-cell resolution. Nucleic Acids Res. 2026;54(D1):D1658\u201371.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"3703_CR14","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, Morris Q. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60\u20134.","journal-title":"Nucleic Acids Res"},{"key":"3703_CR15","doi-asserted-by":"publisher","first-page":"101343","DOI":"10.1016\/j.redox.2019.101343","volume":"28","author":"Z Wang","year":"2020","unstructured":"Wang Z, Sun R, Wang G, Chen Z, Li Y, Zhao Y, Liu D, Zhao H, Zhang F, Yao J, Tian X. SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia\/reperfusion injury. Redox Biol. 2020;28:101343.","journal-title":"Redox Biol"},{"issue":"4","key":"3703_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41423-024-01135-z","volume":"21","author":"Z Wu","year":"2024","unstructured":"Wu Z, Lamao Q, Gu M, Jin X, Liu Y, Tian F, Yu Y, Yuan P, Gao S, Fulford TS, Uldrich AP, Wong CC, Wei W. Unsynchronized butyrophilin molecules dictate cancer cell evasion of V\u03b39V\u03b42 T-cell killing. Cell Mol Immunol. 2024;21(4):362\u201373.","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"3703_CR17","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1158\/1541-7786.MCR-21-0886","volume":"20","author":"X Gong","year":"2022","unstructured":"Gong X, Karchin R, Pan-Cancer HLA. Gene-Mediated Tumor Immunogenicity and Immune Evasion. Mol Cancer Res. 2022;20(8):1272\u201383.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"3703_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12935-024-03248-x","volume":"24","author":"PJ Chua","year":"2024","unstructured":"Chua PJ, Ow SH, Ng CT, Huang WH, Low JT, Tan PH, Chan MWY, Bay BH. Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression. Cancer Cell Int. 2024;24(1):59.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"3703_CR19","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/s12276-024-01277-0","volume":"56","author":"W Su","year":"2024","unstructured":"Su W, Guo Y, Wang Q, Ma L, Zhang Q, Zhang Y, Geng Y, Jin T, Guo J, Yang R, Niu Z, Ren L, Wang Y, Ning Z, Li W, He W, Sun J, Li T, Li Z, Shan H, Liang H. YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis. Exp Mol Med. 2024;56(7):1643\u201354.","journal-title":"Exp Mol Med"},{"issue":"5","key":"3703_CR20","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.apsb.2022.12.009","volume":"13","author":"W Wei","year":"2023","unstructured":"Wei W, Zeng Q, Wang Y, Guo X, Fan T, Li Y, Deng H, Zhao L, Zhang X, Liu Y, Shi Y, Zhu J, Ma X, Wang Y, Jiang J, Song D. Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. Acta Pharm Sin B. 2023;13(5):2138\u201351.","journal-title":"Acta Pharm Sin B"},{"key":"3703_CR21","doi-asserted-by":"publisher","first-page":"216587","DOI":"10.1016\/j.canlet.2023.216587","volume":"582","author":"Y Meng","year":"2024","unstructured":"Meng Y, Lin W, Wang N, Wei X, Mei P, Wang X, Zhang C, Huang Q, Liao Y. USP7-mediated ER\u03b2 stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma. Cancer Lett. 2024;582:216587.","journal-title":"Cancer Lett"},{"key":"3703_CR22","doi-asserted-by":"publisher","first-page":"116155","DOI":"10.1016\/j.ecoenv.2024.116155","volume":"273","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zeng JM, Zhao H, Ao CY, Ao LH, Ban JQ, Li J. Mechanism of KAT2A regulation of H3K36ac in manganese-induced oxidative damage to mitochondria in the nervous system and intervention by curcumin. Ecotoxicol Environ Saf. 2024;273:116155.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"10\u201312","key":"3703_CR23","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/ars.2022.0137","volume":"40","author":"Y Hu","year":"2024","unstructured":"Hu Y, Tian X, Zhao Y, Wang Z, Lin M, Sun R, Wang Y, Wang Z, Li G, Zheng S, Yao J. Sirtuin 5 Alleviates Liver Ischemia\/Reperfusion Injury by Regulating Mitochondrial Succinylation and Oxidative Stress. Antioxid Redox Signal. 2024;40(10\u201312):616\u201331.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3703_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12931-024-02739-9","volume":"25","author":"W Huang","year":"2024","unstructured":"Huang W, Wang L, Huang Z, Sun Z, Zheng B. Peroxiredoxin 3 has a crucial role in the macrophage polarization by regulating mitochondrial homeostasis. Respir Res. 2024;25(1):110.","journal-title":"Respir Res"},{"issue":"7672","key":"3703_CR25","first-page":"501","volume":"649","author":"K Wu","year":"2025","unstructured":"Wu K, Vaughan AJ, Bossowski JP, Hao Y, Ziogou A, Kim SM, Kim TH, Nakamura MN, Pillai R, Mancini M, Rajalingam S, Han M, Nakamura T, Wang L, Chung S, Simeone D, Shackelford D, Kang YP, Conrad M, Papagiannakopoulos T. Targeting FSP1 triggers ferroptosis in lung cancer. Nature. 2025;649(7672):501\u20138.","journal-title":"Nature"},{"issue":"1","key":"3703_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12943-020-01209-2","volume":"19","author":"Q Kong","year":"2020","unstructured":"Kong Q, Xiang Z, Wu Y, Gu Y, Guo J, Geng F. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection. Mol Cancer. 2020;19(1):80.","journal-title":"Mol Cancer"},{"key":"3703_CR27","doi-asserted-by":"publisher","first-page":"110316","DOI":"10.1016\/j.biopha.2020.110316","volume":"128","author":"Q Kong","year":"2020","unstructured":"Kong Q, Wu Y, Gu Y, Lv Q, Qi F, Gong S, Chen X. Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools. Biomed Pharmacother. 2020;128:110316.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"3703_CR28","doi-asserted-by":"publisher","first-page":"e70306","DOI":"10.1002\/iid3.70306","volume":"13","author":"Z Zang","year":"2025","unstructured":"Zang Z, Kong Y, Kong Q. Cordyceps sinensis (CS) Alleviates Chronic Obstructive Pulmonary Disease Symptoms (COPD) by Targeting Inflammation, Apoptosis, and Oxidative Stress Through Ingredient\u2013Gene\u2013Disease Interaction. Immun Inflamm Dis. 2025;13(12):e70306.","journal-title":"Immun Inflamm Dis"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03703-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03703-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03703-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:02:46Z","timestamp":1782777766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03703-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3703"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03703-5","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require ethics approval or informed consent, as it involved the analysis of publicly available de-identified data and bioinformatics tools with no human subjects or laboratory animals involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}